Capivasertib
Brand name: Truqap
Capivasertib comes in 4 pill versions in our database, in 2 strengths, from 2 manufacturers. Check the imprint to tell them apart.
Capivasertib pill images
160 mg 2 pills
- CAV 160 Capivasertib 160 mg Brown, round, 10 mm Used for breast cancer
- CAV 160 Capivasertib 160 mg Brown, round Used for breast cancer
200 mg 2 pills
What is Capivasertib used for?
Capivasertib is used for breast cancer.
Official uses from the US prescribing label
HR-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer
TRUQAP, in combination with fulvestrant, is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer with one or more PIK3CA/AKT1/PTEN-alteration as detected by an FDA-authorized test following progression on at least one endocrine-based regimen in the metastatic setting or recurrence on or within 12 months of completing adjuvant therapy.
PTEN-Deficient Metastatic Androgen Pathway Modulation-Naïve or -Sensitive Prostate Cancer
TRUQAP, in combination with abiraterone and prednisone, is indicated for the treatment of adult patients with metastatic androgen pathway modulation-naïve or -sensitive (mAPMN/S) prostate cancer that is PTEN-deficient as detected by an FDA-authorized test.
From the FDA-approved label on DailyMed (published Sep 28, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.